Literature DB >> 6497779

Microsomal protein synthesis and induction of cytochrome P-450 in cirrhotic rat liver.

G C Farrell, L Zaluzny.   

Abstract

In order to determine whether non-specific defects of protein synthesis account for reduced levels of cytochrome P-450 in cirrhotic liver, total microsomal protein synthesis and response to microsomal enzyme-inducing agents have been examined in rats. Cirrhosis was produced by administration of carbon tetrachloride (CCl4) and phenobarbitone for 10 weeks. Ten days after stopping these agents, cytochrome P-450 levels were 30% lower in cirrhotic liver than in controls (p less than 0.0001). However, total microsomal protein synthesis, determined in vivo by administration of [3H]-leucine, was similar in cirrhotic (1347 +/- 420 dpm/mg protein) and control (1317 +/- 303 dpm/mg protein) liver. Three separate types of microsomal enzyme-inducing agents, phenobarbitone, beta-naphthoflavone, and pregnenolone 16 alpha-carbonitrile, were administered to cirrhotic and normal rats. In both groups of animals increases of total cytochrome P-450 and selective changes of cytochrome P-450 isoenzymes (assessed by mixed function oxidase activity towards four substrates) were qualitatively and quantitatively similar. It is concluded that hepatocytes of cirrhotic rat liver synthesize microsomal protein at a normal rate but less of it is cytochrome P-450, and the entire process of enzyme induction is intact. Thus, it appears likely that altered regulation of basal levels of cytochrome P-450 rather than an altered response of the liver is responsible for the lowered cytochrome P-450 content of cirrhotic rat liver.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6497779     DOI: 10.1038/icb.1984.29

Source DB:  PubMed          Journal:  Aust J Exp Biol Med Sci        ISSN: 0004-945X


  4 in total

Review 1.  Pharmacokinetic drug interactions in liver disease: An update.

Authors:  Pietro Palatini; Sara De Martin
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

2.  Severe liver cirrhosis markedly reduces AhR-mediated induction of cytochrome P450 in rats by decreasing the transcription of target genes.

Authors:  Maura Floreani; Sara De Martin; Daniela Gabbia; Massimo Barbierato; Alberto Nassi; Claudia Mescoli; Rocco Orlando; Sergio Bova; Paolo Angeli; Elisabetta Gola; Antonietta Sticca; Pietro Palatini
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

3.  Pregnane X receptor and constitutive androstane receptor modulate differently CYP3A-mediated metabolism in early- and late-stage cholestasis.

Authors:  Daniela Gabbia; Arianna Dalla Pozza; Laura Albertoni; Roberta Lazzari; Giorgia Zigiotto; Maria Carrara; Vincenzo Baldo; Tatjana Baldovin; Annarosa Floreani; Sara De Martin
Journal:  World J Gastroenterol       Date:  2017-11-14       Impact factor: 5.742

4.  Effect of the severity of liver dysfunction on the minimum alveolar concentration of sevoflurane responding to an electronic stimulation in cirrhotic patients.

Authors:  Yan Yin; Hong Xiao; Jirimutuya Han; Weiyi Zhang; Jianguo Cheng; Tao Zhu
Journal:  BMC Anesthesiol       Date:  2016-10-18       Impact factor: 2.217

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.